image
uniQure N.V. QURE
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 6.205
-8.07 %
$ 302 M
Market Cap
-1.25
P/E
BALANCE SHEET
832 M ASSETS
17.98%
Growth Rates
1Year 17.98%
3Years 34.69%
5Years 24.87%
7Years 23.46%
10Years 31.49%
624 M LIABILITIES
172.55%
Growth Rates
1Year 172.55%
3Years 86.31%
5Years 45.93%
7Years 25.59%
10Years 29.75%
208 M EQUITY
-56.37%
Growth Rates
1Year -56.37%
3Years -5.22%
5Years 2.95%
7Years 18.41%
10Years 39.05%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition uniQure N.V.
image
Current Assets 652 M
Cash & Short-Term Investments 618 M
Receivables 4.19 M
Other Current Assets 29.8 M
Non-Current Assets 180 M
Long-Term Investments 0
PP&E 75.3 M
Other Non-Current Assets 104 M
Current Liabilities 73.7 M
Accounts Payable 6.59 M
Short-Term Debt 16.7 M
Other Current Liabilities 50.4 M
Non-Current Liabilities 550 M
Long-Term Debt 130 M
Other Non-Current Liabilities 420 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010
ASSETS
Cash & Cash Equivalents 241.4 228.0 556.3 244.9 377.8 234.9 159.4 132.5 222.5 64.7 32.9 0.3 1.4 23.8
Short Term Investments 376.5 124.8 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 4.2 102.4 58.8 6.6 0.9 0.2 1.6 9.2 4.1 4.2 3.6 1.1 1.4 0.9
Inventory 12.0 6.9 10.5 4.3 4.7 1.1 1.1 1.0 0.5 0.2 1.2 (1.1) 0 1
Other Current Assets 17.7 14.6 13.2 7.4 5.5 1.4 1.8 2.3 1.9 0.9 3.5 0 0 0.000001
Total Current Assets 651.9 476.8 628.2 258.9 384.2 236.6 162.8 143.9 229.0 69.8 38.2 1.5 2.8 24.6
PP&E 75.3 83.3 69.1 58.4 55.6 29.2 34.3 35.7 26.0 23.9 3.6 1.6 1.2 1.7
Intangible Assets 60.5 58.8 62.7 3.4 5.4 5.2 8.8 8.3 7.9 19.9 10.7 4.3 3.5 3.9
Goodwill 26.4 25.6 27.6 0.5 0.5 0.5 0.5 0.5 0.5 1.6 0 0 0 0
Long Term Investments 0 40.0 0 2.7 2.9 2.4 2.5 1.8 1.2 0 0 0 0 0
Other Long Term Assets 5.4 6.1 5.9 0 2.9 2.4 2.5 1.8 1.2 1.2 1.3 0 1 1
Other Assets 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Total Assets 831.7 705.0 809.2 340.4 448.6 273.9 208.9 190.3 264.7 116.5 53.8 7.4 7.5 30.2
LIABILITIES
Accounts Payable 6.6 11.0 2.5 3.8 5.7 3.8 2.9 5.5 4.1 3.9 4.8 0.8 2.3 2.1
Short Term Debt 16.7 16.8 11.5 11.0 (1.2) 0 1.1 0.6 5.6 0.8 1.2 0 0 0
Other Current Liabilities 50.4 48.2 22.7 13.2 12.5 8.5 10.7 9.3 16.4 7.4 5.6 6.4 1.6 3.3
Total Current Liabilities 73.7 75.9 36.8 27.3 31.6 20.0 19.3 22.7 26.7 14.9 14.4 7.4 4.8 5.6
Long Term Debt 130.1 134.5 129.9 66.0 67.2 35.5 19.7 19.6 14.6 20.1 9.1 0.6 0.2 0.3
Deferred Tax Income 7.5 8.3 12.9 0 3.1 9.6 10.4 6.8 6.9 1.7 0 0 0 0
Other Liabilities 412.7 10.3 33.8 3.1 3.6 10.0 13.9 8.7 85.9 8.4 (7.8) 0 5.9 6.1
Total Liabilities 624.0 229.0 213.4 96.5 125.6 94.3 118.9 126.6 134.1 64.1 46.1 8.0 10.9 12.0
EQUITY
Common Stock 2.9 2.8 2.8 2.7 2.7 2.3 1.9 1.6 1.3 1.1 0.8 0.6 0.3 0.3
Retained Earnings (890.4) (581.9) (455.1) (784.7) (659.7) (535.5) (467.1) (396.1) (276.1) (220.2) (198.9) (155.0) (136.7) (117.3)
Other Accumulative Comprehensive Income/Loss (53.6) (58.3) (28.9) 9.9 (6.7) (7.3) 39.1 (6.6) 28.5 20.9 9.0 2.0 3.5 2.4
Total Equity 207.7 476.0 595.8 243.9 323.1 179.6 89.9 63.6 130.6 52.4 7.7 (0.6) (3.4) 18.2
Total Liabilities and Equity 831.7 705.0 809.2 340.4 448.6 273.9 208.9 190.3 264.7 116.5 53.8 7.4 7.5 30.2
SHARES OUTSTANDING
Common Shares Outstanding 47.7 46.7 46.0 44.5 40.0 35.6 27.0 25.0 22.1 17.1 17.6 17.6 17.6